Related references
Note: Only part of the references are listed.The Origin and Pathogenesis of Epithelial Ovarian Cancer: A Proposed Unifying Theory
Robert J. Kurman et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2010)
Oestrogen-induced epithelial-mesenchymal transition of endometrial epithelial cells contributes to the development of adenomyosis
Yi-Jen Chen et al.
JOURNAL OF PATHOLOGY (2010)
High-grade fimbrial-ovarian carcinomas are unified by altered p53, PTEN and PAX2 expression
Michael H. Roh et al.
MODERN PATHOLOGY (2010)
Primary ex vivo cultures of human fallopian tube epithelium as a model for serous ovarian carcinogenesis
K. Levanon et al.
ONCOGENE (2010)
Genetic Analysis of the Early Natural History of Epithelial Ovarian Carcinoma
Bhavana Pothuri et al.
PLOS ONE (2010)
Multistep Level Sections to Detect Occult Fallopian Tube Carcinoma in Risk-reducing Salpingo-oophorectomies From Women With BRCA Mutations Implications for Defining an Optimal Specimen Dissection Protocol
Joseph T. Rabban et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2009)
Precursors to pelvic serous carcinoma and their clinical implications
Ann K. Folkins et al.
GYNECOLOGIC ONCOLOGY (2009)
Intercepting pelvic cancer in the distal fallopian tube: Theories and realities
Christopher P. Crum
MOLECULAR ONCOLOGY (2009)
Expression of Pax8 as a useful marker in distinguishing ovarian carcinomas from mammary carcinomas
Daisuke Nonaka et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2008)
Tubal and ovarian pathways to pelvic epithelial cancer: a pathological perspective
E. A. Jarboe et al.
HISTOPATHOLOGY (2008)
New Insights Into the Pathogenesis of Serous Ovarian Cancer and Its Clinical Impact
Keren Levanon et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Serous tubal Intraepithelial carcinoma: Its potential role in primary peritoneal serous carcinoma and serous cancer prevention
Joseph W. Carlson et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
The cell of origin of ovarian epithelial tumours
Louis Dubeau
LANCET ONCOLOGY (2008)
Primary Fallopian tube malignancies in BRCA-positive women undergoing surgery for ovarian cancer risk reduction
Michael J. Callahan et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Emerging roles for PAX8 in ovarian cancer and endosalpingeal development
Nathan J. Bowen et al.
GYNECOLOGIC ONCOLOGY (2007)
Congenital hypothyroid female Pax8-deficient mice are infertile despite thyroid hormone replacement therapy
Jens Mittag et al.
ENDOCRINOLOGY (2007)
Intraepithelial carcinoma of the fimbria and pelvic serous carcinoma: Evidence for a causal relationship
David W. Kindelberger et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2007)
PAX genes: Roles in development, pathophysiology, and cancer
Deborah Lang et al.
BIOCHEMICAL PHARMACOLOGY (2007)
A candidate precursor to serous carcinoma that originates in the distal fallopian tube
Y. Lee et al.
JOURNAL OF PATHOLOGY (2007)
KRAS and BRAF mutations in ovarian tumors:: A comprehensive study of invasive carcinomas, borderline tumors and extraovarian implants
Doris Mayr et al.
GYNECOLOGIC ONCOLOGY (2006)
Salpingo-oophorectomy and the risk of ovarian, fallopian tube, and peritoneal cancers in women with a BRCA1 or BRCA2 mutation
Amy Finch et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
The diagnostic utility of immunohistochemistry and electron microscopy in distinguishing between peritoneal mesotheliomas and serous carcinomas: a comparative study
NG Ordonez
MODERN PATHOLOGY (2006)
Different proportions of aneusomic cells in ovarian inclusion cysts associated with serous borderline tumours and serous high-grade carcinomas support different pathogenetic pathways
M Körner et al.
JOURNAL OF PATHOLOGY (2005)
Grading ovarian serous carcinoma using a two-tier system
A Malpica et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2004)
In ovarian neoplasms, BRAF, but not KRAS, mutations are restricted to low-grade serous tumours
NLG Sieben et al.
JOURNAL OF PATHOLOGY (2004)
Mutations of BRAF and KRAS precede the development of ovarian serous borderline tumors
CL Ho et al.
CANCER RESEARCH (2004)
Mutations in BRAF and KRAS characterize the development of low-grade ovarian serous carcinoma
G Singer et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2003)
Unexpected gynecologic neoplasms in patients with proven or suspected BRCA-1 or-2 mutations - Implications for gross examination, cytology, and clinical follow-up
SN Agoff et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2002)
Value of mesothelial and epithelial antibodies in distinguishing diffuse peritoneal mesothelioma in females from serous papillary carcinoma of the ovary and peritoneum
RL Attanoos et al.
HISTOPATHOLOGY (2002)
Expression of calretinin in human ovary, testis, and ovarian sex cord-stromal tumors
QJ Cao et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY (2001)
K-ras mutations in Mullerian inclusion cysts associated with serous borderline tumors of the ovary
AA Alvarez et al.
GYNECOLOGIC ONCOLOGY (2001)
Share Paper
